GlobeNewswire Inc.··Rhythm Pharmaceuticals, Inc.Rhythm Pharma Wins FDA Nod for First-Ever Acquired Obesity Treatment
Rhythm Pharma wins FDA approval for IMCIVREE, the first therapy for acquired hypothalamic obesity, based on 18.4% placebo-adjusted BMI reduction.
RYTMFDA approvalrare disease